Along with other roles of chemerin revealed in cancer, such as angiogenesis [56] and PD-L1/PD-1 axis regulation [39, 57], focusing on chemerin/CMKLR1 axis blockade may help develop effective therapeutics targeting mesenchymal GBM. This evidence concerns the gene RARRES2 and glioblastoma.